Skip to main content

Kiromic BioPharma, Inc. (NASDAQ: KRBP) Investor Securities Class Action Lawsuit 08/05/2022

  • If you purchased a significant amount of shares of Kiromic BioPharma, Inc. (NASDAQ: KRBP) between June 25, 2021 and August 13, 2021 and/or in connection with The Company’s public offering closed on July 2, 2021, and / or if you purchased any NASDAQ: KRBP shares prior to June 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 4, 2022. NASDAQ: KRBP investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 29, 2023 - The parties entered into a stipulation of settlement. December 21, 2022 - A consolidated complaint was filed. August 05, 2022 - An investor in shares of Kiromic BioPharma, Inc. (NASDAQ: KRBP) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Kiromic BioPharma, Inc. in connection w...



You must register (for free) or login to view the entire case.